American Lung Association

New report outlines health impact of air pollution from MidAmerican Energy coal plants in Siouxland

Retrieved on: 
tisdag, maj 7, 2024
Education, Organization, University, Public, Physicians for Social Responsibility, MPA, Organic compound, MidAmerican Energy Company, Environmental Health (journal), Chronic obstructive pulmonary disease, Lung cancer, SO2, IEC, Health, Heart, Volatile organic compound, American Lung Association, Partnership, Electricity, Doctor of Philosophy, Employment, Nitrogen, Plant, Public policy, Council, Social responsibility, Sulfur dioxide, Poverty, NOx, Mercury, Multimedia, Air pollution, University of Iowa, Asthma, Winnebago Tribe of Nebraska, COPD

DES MOINES, Iowa, May 7, 2024 /PRNewswire/ -- A new report from the Iowa Environmental Council, released on World Asthma Day, examines the relationship between pollution from coal plants and lung disease in Woodbury County.

Key Points: 
  • Written in partnership with public health experts from organizations including the American Lung Association, Physicians for Social Responsibility, and the Winnebago Tribe of Nebraska's Winnebago Comprehensive Healthcare System, Coal in Siouxland: MidAmerican Energy's Legacy of Air Pollution and Health Impacts highlights how two coal-fired power plants in northwest Iowa operated by MidAmerican Energy harm the health of Siouxland, the multi-state, three county region surrounding Sioux City, IA.
  • "Pollution from coal plants makes our communities sicker and drives worse health outcomes, especially for communities of color and Iowans of low-income."
  • "Emissions from coal plants pose a serious threat to public health in Iowa," says John Rachow, MD, PhD, Past President of Physicians for Social Responsibility.
  • "The data in this report raise troubling questions for us and should be concerning to all Iowans and to MidAmerican Energy," says Smith.

Ideal Living Launches New AirDoctor 2500 Air Purifier to Combat Rising Air Pollution Levels, Improve Air Quality for Americans

Retrieved on: 
onsdag, maj 1, 2024
Environment, Commercial Building & Real Estate, Construction & Property, Health Technology, Home Goods, Building Systems, Health, Retail, Residential Building & Real Estate, VOC, Organic compound, Living, Bacteria, Pollen, American Lung Association, Research, Ozone, Carbon, Dust, Spore, Virus, Multimedia, Air pollution, Formaldehyde, Environmental remediation

Ideal Living , maker of AirDoctor and AquaTru, today announced the launch of the AirDoctor 2500 Wall Mounted Air Purifier.

Key Points: 
  • Ideal Living , maker of AirDoctor and AquaTru, today announced the launch of the AirDoctor 2500 Wall Mounted Air Purifier.
  • View the full release here: https://www.businesswire.com/news/home/20240501191991/en/
    As the new addition to the air purifier product lineup , AirDoctor 2500 arrives as air pollution continues to rise in the U.S.
  • AirDoctor 2500 addresses this problem by efficiently circulating air multiple times per hour to maintain high air quality.
  • "Air pollution is a very real problem, as evidenced by increasing ozone and particle pollution levels in recent years.

Viz.ai Wins 2024 Edison Award™ for Innovation for Second Year in a Row

Retrieved on: 
fredag, april 19, 2024
Cardiology, Biotechnology, Technology, Other Health, Health, General Health, Optical, Health Technology, Infectious Diseases, Software, Artificial Intelligence, Education, Mortality, FDA, AI, AVF, Triage, American Lung Association, Partnership, Artificial intelligence, Pulmonary embolism, Assessment, Engineering, Science, PERT, Edison Award, Edison Awards, Circulatory system, Thomas Edison, Multimedia, Marketing, Diagnosis, Viz

Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named an Edison Award Winner in the 2024 Edison Awards, for the second year in a row.

Key Points: 
  • Viz.ai, the leader in AI-powered disease detection and intelligent care coordination, today announced that it has been named an Edison Award Winner in the 2024 Edison Awards, for the second year in a row.
  • The prestigious Edison Awards, named after the American inventor Thomas Alva Edison, honor excellence in new product and service development, marketing, design and innovation.
  • View the full release here: https://www.businesswire.com/news/home/20240419954371/en/
    “We are honored to win our second Edison Award for innovation,” said Dr. Chris Mansi, CEO and co-founder of Viz.ai.
  • Winners were announced at the Edison Awards Gala on April 18, 2024 in Fort Myers, FL.

2024 'State of the Air' Report Reveals Most 'Hazardous' Air Quality Days in 25 Years

Retrieved on: 
onsdag, april 24, 2024
Climate change, Smog, Atmosphere of Earth, City, EPA, Weather, Lung cancer, Health, Diabetes, American Lung Association, Wildfire, Ozone, History, Stroke, Splenic infarction, Child, Annual report, Asthma, Soot, Air pollution, Coal

CHICAGO, April 24, 2024 /PRNewswire/ -- The American Lung Association's new "State of the Air" report reveals that spikes in deadly particle pollution are the most severe they've been in the history of the report. According to the new report, people in the U.S. experienced the most days with "very unhealthy" and "hazardous" air quality due to particle pollution in 25 years. In total, the report finds that 131 million people (39%) are living in areas with unhealthy levels of air pollution.

Key Points: 
  • According to the new report, people in the U.S. experienced the most days with "very unhealthy" and "hazardous" air quality due to particle pollution in 25 years.
  • In total, the report finds that 131 million people (39%) are living in areas with unhealthy levels of air pollution.
  • This year's report includes the most recent quality-assured air quality data from 2020-2022 and is updated to reflect the new annual particle pollution standard that the U.S. Environmental Protection Agency (EPA) finalized in February 2024.
  • "We have seen impressive progress in cleaning up air pollution over the last 25 years, thanks in large part to the Clean Air Act.

New Campaign Highlights How Certain Jobs Can Increase a Person's Risk for Lung Disease

Retrieved on: 
tisdag, april 9, 2024
Pneumonia, Emphysema, Bronchitis, Disease, Tobacco, Agriculture, Risk, Urinary tract infection, Spirometry, Fatigue, Smoke, Quality of life, Sputum, Dust, Mucus, Smoking, Wheeze, American Lung Association, COPD, Air pollution, Workplace, Phlegm, Ageing, Mining, Nursing

CHICAGO, April 9, 2024 /PRNewswire/ -- Chronic obstructive pulmonary disease (COPD) impacts 11.7 million people living in the U.S. While smoking is a significant risk factor for the disease, long-term exposure to dust, chemicals, fumes and vapors from the workplace may also lead to COPD. To help people identify workplace risk factors and encourage them to speak with their healthcare provider if they are experiencing symptoms, the American Lung Association is launching a campaign to raise awareness for occupational COPD. 

Key Points: 
  • While smoking is a significant risk factor for the disease, long-term exposure to dust, chemicals, fumes and vapors from the workplace may also lead to COPD.
  • COPD, which includes chronic bronchitis and emphysema, is a long-term lung disease that makes it hard to breathe.
  • Many workplaces may expose workers to risk factors for COPD, but the leading job types that increase risk for chronic lung disease include agriculture, mining and manufacturing.
  • Early treatment of a chronic lung disease, including reducing the exposure, can help lead to better health outcomes.

American Lung Association and LUNGevity Foundation Announce $3 Million Research Partnership to Intercept Lung Cancer

Retrieved on: 
tisdag, april 9, 2024
Boston University, Lung cancer, Enzyme, Disease, Health equity, Partnership, Patient, Research, Doctor of Philosophy, Helpline, MD, Quality of life, Protein, Master of Science, Clinical trial, Partial, Johnson & Johnson, Interventional oncology, American Lung Association, UCLA, Charity Navigator, Cancer, Estate (law), Medical imaging

In a collaborative effort to end this devastating disease, the American Lung Association and LUNGevity Foundation have joined forces to invest $3 million over the next three years in research aimed at intercepting lung cancer – catching precancerous cells and blocking them from turning into cancer cells.

Key Points: 
  • In a collaborative effort to end this devastating disease, the American Lung Association and LUNGevity Foundation have joined forces to invest $3 million over the next three years in research aimed at intercepting lung cancer – catching precancerous cells and blocking them from turning into cancer cells.
  • The partnership builds upon previous collaborations, including research funded by American Lung Association, LUNGevity Foundation and Stand Up To Cancer, which has yielded significant findings in lung cancer interception.
  • Through initiatives like the American Lung Association Research Institute Accelerator Program and the LUNGevity Early Lung Cancer Center , this partnership aims to accelerate progress in lung cancer interception research and pave the way for personalized treatments for patients.
  • LUNGevity, the nation's leading lung cancer organization, is transforming what it means to be diagnosed and live with lung cancer.

CVS Health® invests more than $3M in organizations improving health outcomes in Phoenix

Retrieved on: 
onsdag, mars 27, 2024
Blood pressure, Depression, Ozone, Overweight, Health, FQHC, Organization, Climate change, CVS, Project, Mental, Native Americans, Diabetes, Pharmacy, Conditional sentence, Patient, Education, CVS Pharmacy, Transport, Death, Quality of life, Senior, Bone density, City, CVS Health, Corporate social responsibility, Body mass index, Smoking, Osteoporosis, Suicide, American Lung Association, Cholesterol, Air pollution, Valleywise Health, Hypertension, Nursing

This announcement was made during a Project Health event in Phoenix and included CVS Health leaders, community organizations and local officials.

Key Points: 
  • This announcement was made during a Project Health event in Phoenix and included CVS Health leaders, community organizations and local officials.
  • "No two communities are the same," said Sheryl Burke, Senior Vice President of Corporate Social Responsibility and Chief Sustainability Officer at CVS Health.
  • With 65% of South Phoenix residents overweight or obese and knowing that 80% of health care costs are primarily due to preventable chronic diseases, CVS Health saw an opportunity to tailor its Health Zones initiative in Phoenix to address the high levels of diabetes and hypertension.
  • In addition to these new grants, CVS Health will offer free health screenings to the Phoenix community through its Project Health program, starting in March.

Olympus Partners with American Lung Association on Patient Education for Lung Cancer Screening

Retrieved on: 
onsdag, mars 27, 2024
Diagnosis, Biopsy, Lung cancer, Medicine, Immunotherapy, Disease, Infection, Partnership, Patient, Sore throat, Perforation, Cancer, United, Olympus Corporation, Senior, Lymph, Bleeding, EUS, American Lung Association, Physician, Medical imaging

CENTER VALLEY, Pa., March 27, 2024 /PRNewswire/ -- Olympus Corporation of the Americas, a global medical technology company committed to making people's lives healthier, safer and more fulfilling, is now partnering with the American Lung Association to educate lung cancer patients about the care pathway for diagnosing and staging lung nodules.

Key Points: 
  • The lung nodules educational resources , sponsored by Olympus, help patients understand the diagnosis and staging process for lung nodules and why it is important to their treatment journey.
  • "Olympus is very excited to support this great new educational resource for lung cancer patients through our partnership with the American Lung Association," said Jovan Reyerson, Senior Vice President of Medical and Scientific Affairs at Olympus Corporation of the Americas.
  • Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA), a procedure pioneered by Olympus, has helped lay the groundwork for targeted cancer treatment such as immunotherapy.
  • Lung cancer remains the leading cause of cancer death in the United States.² Early detection of lung cancer is key as the 5-year relative survival rate for non-small cell lung cancer is about 65% when caught at a localized stage.

Navigating Lung Cancer: 5 Essential Facts Families Should Know About Lung Nodules and Staging

Retrieved on: 
onsdag, mars 27, 2024
Diagnosis, Lung cancer, Metastasis, X-ray, Patient, Research, Cancer, Hope, Lymph, American Lung Association, Prognosis, Physician, Family, Primary tumor, Medical imaging

CHICAGO, March 27, 2024 /PRNewswire/ -- About every two and a half minutes, someone in the U.S. is diagnosed with lung cancer. The diagnosis process usually starts with a suspected "nodule." The process of "suspected nodule" to treatment (or other next steps) can be confusing to a person impacted and their family. To help empower people who are newly diagnosed with lung cancer with critical knowledge about lung nodules, staging and treatment, the American Lung Association and Olympus partnered to launch a new educational campaign.

Key Points: 
  • To help empower people who are newly diagnosed with lung cancer with critical knowledge about lung nodules, staging and treatment, the American Lung Association and Olympus partnered to launch a new educational campaign .
  • While it may seem like a simple step in the diagnostic process, staging lung cancer can be complicated.
  • Here are five things that people should know about lung cancer staging:
    There are 3 main scenarios in which lung nodules are found: Lung nodules show up on imaging tests like X-rays and CT scans.
  • The Lung Association has new resources about staging and lung nodules: Through this campaign, resources are available to provide more information about lung nodules and staging at Lung.org/lung-nodules .

GSK Doubles COiMMUNITY Grant Funding, Launches Patient Resources, as Adult Vaccination Rates Begin to Show Promising Rise

Retrieved on: 
torsdag, mars 7, 2024
Infectious Diseases, General Health, Health, Other Health, Inflation, Senior, Immunization, GSK, Education, Physician, Hope, Entrepreneurship, Vaccine, Vaccination, American Lung Association, Patient, Request, IRA, Health equity, Infection, Medicaid, GSK plc, Pharmaceutical industry

GSK plc (LSE/NYSE: GSK) today announced additional funding and new data and resources under the COiMMUNITY Initiative to help achieve higher adult vaccination rates and health equity in the US and address ongoing barriers to adult immunization.

Key Points: 
  • GSK plc (LSE/NYSE: GSK) today announced additional funding and new data and resources under the COiMMUNITY Initiative to help achieve higher adult vaccination rates and health equity in the US and address ongoing barriers to adult immunization.
  • The COiMMUNITY Initiative complements recent industry and regulatory efforts to expand and improve adult vaccine availability, coverage and access.
  • GSK is equipping healthcare providers and their patients with simple tools to spur action and follow through on vaccination.
  • GSK will also continue to share new resources, tools and best practices in adult vaccine confidence and delivery via interactive webinars.